When reporters questioned the FDA for comment, the company repeated facts from earlier news releases about the Diamond Shruumz investigation and remember and stated it would not focus on doable or ongoing inquiries.Mainly because of the not enough regulation in The grey-market place psilocybin industry, there’s a superior threat of currently bein